November 17, 2020
November 12, 2020
Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows
Thermo Fisher Scientific, the world leader in serving science, and the Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University, have entered into a collaborative... Read More
November 12, 2020
Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform
Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce the completion... Read More
November 12, 2020
LUNGevity Foundation Launches Inhale for Life: Right Track Public Service and Social Media Campaign During Lung Cancer Awareness Month
Kicking off Lung Cancer Awareness Month, LUNGevity, the nation’s leading lung cancer-focused nonprofit organization, launched its Inhale for Life: Right Track public service campaign.... Read More
November 12, 2020
Caris Life Sciences Announces Huntsman Cancer Institute Joins its Precision Oncology Alliance
Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that Huntsman Cancer Institute (HCI)... Read More
October 27, 2020
Exact Sciences to Acquire Thrive Earlier Detection, Becoming a Leader in Blood-Based, Multi-Cancer Screening
Exact Sciences Corp. (Nasdaq: EXAS) and Thrive Earlier Detection Corp. (“Thrive”), a healthcare company dedicated to incorporating earlier cancer detection into routine medical care,... Read More
October 1, 2020
19 Organizations from the Healthcare Community Unite to Form COVID-19 Testing Industry Consortium
Widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19, is one critical aspect needed to limit the spread of the disease. By creating... Read More
October 1, 2020
Sema4 Announces Collaboration with Janssen on Optimizing Oncology Clinical Trials
Sema4, a patient-centered health intelligence company, today announced that it has entered into a research agreement with Janssen Research & Development, LLC (Janssen) to... Read More
October 1, 2020
Ionis and Genuity Science announce agreement designed to rapidly translate genomic insights into therapeutics
Genuity Science, a genomics and data insights organization and Ionis Pharmaceuticals (NASDAQ: IONS), the leader in antisense therapeutics, today announced a broad, multi-year collaboration... Read More
October 1, 2020
Cancer Genomic Screening Program LC-SCRUM-Asia Adopts Latest Thermo Fisher Scientific NGS Solutions
LC-SCRUM-Asia, a leading cancer genomic screening program, has selected Thermo Fisher Scientific’s Ion Torrent Genexus System* and Oncomine Precision Assay*, a pan-cancer panel, to... Read More
September 10, 2020
Bristol Myers Squibb Research at ESMO Virtual Congress 2020 Highlights Significant Progress in Cancers with High Unmet Medical Need
Bristol Myers Squibb (NYSE:BMY) today announced the presentation of research spanning 15 different cancers at the upcoming European Society for Medical Oncology (ESMO) Virtual... Read More
September 10, 2020
AstraZeneca aims to transform cancer treatment and advance clinical practice with data presented at ESMO 2020
AstraZeneca will present new developments in pursuit of its ambition to eliminate cancer as a cause of death at the European Society for Medical... Read More
September 10, 2020
Natera Launches Proposed Follow-On Offering
Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA testing, today announced the launch of a proposed follow-on public offering of $250,000,000 of... Read More
September 10, 2020
Lilly Oncology to Showcase New Data from Robust Cancer Research Pipeline at ESMO Virtual Congress 2020
Data from 20 studies across Eli Lilly and Company’s (NYSE: LLY) oncology product portfolio will be presented at the European Society for Medical Oncology... Read More
September 10, 2020
FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer
The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx)... Read More
September 3, 2020
Blueprint Medicines Strengthens Leadership with Appointment of Fouad Namouni, M.D., as President, Research & Development
Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced the appointment of... Read More
September 3, 2020
U.S. Food and Drug Administration Approves Onureg® (azacitidine tablets), a New Oral Therapy, as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemia
Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Onureg® (azacitidine 300 mg tablets, CC-486) for... Read More
September 3, 2020
Thermo Fisher Scientific Introduces Hematology-Oncology Portfolio for Ion Torrent Genexus System*
In hematology oncology, it is critically important to understand the genetics driving acute malignancies to quickly determine how best to address the disease. Today,... Read More
August 17, 2020
Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Hengrui Therapeutics, Inc.T
Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Hengrui Therapeutics, Inc. (HTI), a U.S. subsidiary of Chinese pharmaceutical company Jiangsu Hengrui... Read More
August 17, 2020
OneOncology and Foundation Medicine Unveil First-of-its-Kind Partnership to Advance Personalized Medicine at Community Oncology Practices
Foundation Medicine, Inc. and OneOncology today announced a new joint initiative that is intended to better enable OneOncology partner practice physicians to unlock the... Read More
August 8, 2020
Bristol Myers Squibb Reports Second Quarter 2020 Financial Results
–Bristol Myers Squibb (NYSE:BMY) today reports results for the second quarter of 2020, which reflect strong product sales, continued advancement of the pipeline and robust... Read More
August 7, 2020
Guardant Health Guardant360® CDx First FDA-Approved Liquid Biopsy for Comprehensive Tumor Mutation Profiling Across All Solid Cancers
Guardant Health, Inc. (Nasdaq: GH) announces that the U.S. Food and Drug Administration (FDA) has approved Guardant360® CDx for tumor mutation profiling, also known... Read More
August 7, 2020
Ancestry® Launches AncestryHealth® Powered by Next Generation Sequencing (NGS)
Ancestry®, the global leader in family history and consumer genomics, today announced the launch of AncestryHealth® powered by Next Generation Sequencing (NGS), signifying a... Read More
July 23, 2020
Genetic testing for heart diseases may help patients and families identify risks
Genetic testing and counseling for inherited cardiovascular diseases may help patients and their families make well-informed decisions about managing their heart health, according to... Read More
July 23, 2020
Konica Minolta Precision Medicine (KMPM) Launches Care for COVID Program
Ambry Genetics Corporation (Ambry), a leading clinical genetic testing laboratory, announced the launch of its CARE for COVID Program to provide employers with the... Read More
Tweets
New post: Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling https://t.co/IH1Rwtrv4t, - Access to care remains a barrier to patients and caregivers across the globe. Join us November 17 as we introduce n… https://t.co/s7TDOhdU1U,
- Precision Medicine News November 12, 2020 - https://t.co/X3QJSaNSAF,